Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1

Interventions

Docetaxel 2tislelizumab 1linifanib 1balugrastim 1atezolizumab 1Tiragolumab 1Radiation 1Paclitaxel 1Filgrastim 1Erlotinib Hydrochloride 1Diathermy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Solid Tumors × balugrastim × Clear all
NCT01940601 2015-01-14

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Withdrawn
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡